glutathion et cancer

glutathion et cancer Glutathione transferases: substrates, inihibitors and pro-drugs in and neurodegenerative diseases Frontiers | Glutathione: Pharmacological aspects

Name: glutathion et cancer Glutathione transferases: substrates, inihibitors and pro-drugs in and neurodegenerative diseases Frontiers | Glutathione: Pharmacological aspects
Brand: lagence-mr.com
SKU: 23754272737
Price: 25.21 USD
Availability: InStock
Rating: 4.2682 (26 reviews)

Frontiers Glutathione: Pharmacological aspects and implications for clinical use in non alcoholic fatty liver disease Human cancer associated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death Cell Death & Disease Reversible glutathionylation of UCP2 and UCP3 serves as a mechanism to Download Scientific Diagram Glutathione mediated nanomedicines for cancer diagnosis and therapy ScienceDirect Utilizing glutathione triggered nanoparticles to enhance chemotherapy of lung cancer by reprograming the tumor microenvironment ScienceDirect

SKU: 23754272737 · From lagence-mr.com

4.3

USD25.21 USD48.21

Pay in 4 interest-free payments of $6.30 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 19 - Sep 24

Description

Morio LA, Leone A, Sawant SP, et al

At 10mg/ml concentration (50mg + 5ml water), a 50mg vial provides: 25 doses at 2mg each 50 doses at 1mg each 16-17 doses at 3mg each This typically supplies 4-8 weeks of use depending on dosing frequency and amount

#A14527) were cultured in HEK TF medium (Sartorius) supplemented with 7 mM GlutaMAX (Gibco) at densities between 0.54.0 10 6 cells/mL at 37 C and 5% CO 2

By targeting the support structures of adipose tissue, it offers a potential solution for morbid obesity models where metabolic variance is insufficient to reverse pathology